prescribed time or such later time as the Director-General or the council, as the case may be, may allow and on payment of the prescribed fee. [S. 22D inserted by s. 14 of Act No. 90 of 1997.] 22E. Suspension and cancellation of licence.—(1) If the holder of a licence under section 22C— (a) has in or in connection with an application for a licence or renewal of a licence furnished the Director-General or the council, as the case may be, with any information which to the knowledge of such holder is untrue or misleading in any material respect; (b) has contravened or failed to comply with a condition upon which the licence was issued; (c) has contravened or failed to comply with a provision of this Act; (d) has, in the case of a licence issued in terms of section 22C (1) (a), at any time been convicted of an offence which is of such a nature that, in the opinion of the Director-General, it renders him or her unsuitable to compound or dispense medicines, the Director-General or the council, as the case may be, may by way of a notice in writing call upon him or her to show cause within the period specified in the notice, which period shall not be less than 20 days as from the date of the notice, why the licence in question should not be suspended or revoked. (2) The Director-General or the council, as the case may be, may after considering the reasons furnished to him or her in terms of subsection (1)— (a) suspend the licence in question for such period as he or she or the council may determine; or (b) revoke the licence in question. (3) No person shall be entitled to the repayment of any prescribed fee in respect of any application for the granting or renewal of a licence if such application has been refused or if the licence has been suspended or revoked. [S. 22E inserted by s. 14 of Act No. 90 of 1997.] 22F. Generic substitution.—(1) Subject to subsections (2), (3) and (4), a pharmacist or a person licensd in terms of section 22C (1) (a) shall— (a) inform all members of the public who visit the pharmacy or any other place where dispensing takes place, as the case may be, with a prescription for dispensing, of the benefits of the substitution for a branded medicine by an interchangeable multi-source medicine, and shall, in the case of a substitution, take reasonable steps to inform the person who prescribed the medicine of such substitution; and [Para. (a) substituted by s. 7 (b) of Act No. 59 of 2002.] Wording of Sections (b) dispense an interchangeable multi-source medicine instead of the medicine prescribed by a medical practitioner, dentist, practitioner, nurse or other person registered under the Health Professions Act, 1974, unless expressly forbidden by the patient to do so. [Sub-s. (1) amended by s. 7 (a) of Act No. 59 of 2002.] Wording of Sections (2) If a pharmacist is forbidden as contemplated in subsection (1) (b), that fact shall be noted by the pharmacist on the prescription. (3) When an interchangeable multi-source medicine is dispensed by a pharmacist he or she shall note the brand name or where no such brand name exists, the name of the manufacturer of that interchangeable multi-source medicine in the prescription book. (4) A pharmacist shall not sell an interchangeable multi-source medicine— (a) if the person prescribing the medicine has written in his or her own hand on the prescription the words “no substitution” next to the item prescribed; (b) if the retail price of the interchangeable multi-source medicine is higher than that of the prescribed medicine; or (c) where the product has been declared not substitutable by the council. [S. 22F inserted by s. 14 of Act No. 90 of 1997.] 22G. Pricing committee.—(1) The Minister shall appoint, for a period not exceeding five years, such persons as he or she may deem fit to be members of a committee to be known as the pricing committee. [Sub-s. (1) substituted by s. 8 (a) of Act No. 59 of 2002.] Wording of Sections (2) The Minister may, on the recommendation of the pricing committee, make regulations— (a) on the introduction of a transparent pricing system for all medicines and Scheduled substances sold in the Republic; (b) on an appropriate dispensing fee to be charged by a pharmacist or by a person licensed in terms of section 22C (1) (a); (c) on an appropriate fee to be charged by wholesalers or distributors or any other person selling Schedule O medicines.